Evaluation of Galectin-3 Levels in GCF And Saliva of Patients With Different Periodontal Diseases

NCT05281796 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2023-11-24

No results posted yet for this study

Summary

The aim of this study is to assess the levels of galectin-3 in the GCF and saliva in patient with gingivitis and patient with stage III periodontitis.

Conditions

  • Periodontal Diseases

Interventions

DIAGNOSTIC_TEST

GCF obtaining

GCF sample collection by Enzyme-Linked Immunosorbent Assay (ELISA)

DIAGNOSTIC_TEST

saliva obtaining

Saliva sample collection by Enzyme-Linked Immunosorbent Assay (ELISA)

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mohamed Sa Ali, master's · Cairo University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-22
Primary Completion
2023-06-15
Completion
2023-08-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05281796 on ClinicalTrials.gov